Phase 1 study of AG-881, an inhibitor of mutant IDH1/IDH2, in patients with advanced IDH-mutant solid tumors, including glioma Meeting Abstract
| Authors: | Mellinghoff, I. K.; Penas-Prado, M.; Peters, K. B.; Cloughesy, T. F.; Burris, H. A.; Maher, E. A.; Janku, F.; Cote, G. M.; De La Fuente, M. I.; Clarke, J.; Steelman, L.; Le, K.; Zhang, Y.; Sonderfan, A.; Hummel, D.; Schoenfeld, S.; Yen, K.; Pandya, S. S.; Wen, P. Y. |
| Abstract Title: | Phase 1 study of AG-881, an inhibitor of mutant IDH1/IDH2, in patients with advanced IDH-mutant solid tumors, including glioma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 87s |
| Language: | English |
| ACCESSION: | WOS:000442916001213 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.2002 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2002 -- Source: Wos |
